Clinical Trial Update: A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical study is evaluating the combination of ruxolitinib and thalidomide for patients with myelofibrosis; the trial status is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Ruxolitinib (ruxolitinib)
• Thalidomide (thalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myelofibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING